QUALITY MATTERS

Epidemiologists are consistently asserting that herd immunity of at least 60% of the population will be required to stem the large number of...

During the COVID-19 pandemic, we have become acutely aware of how precious time is and the potential repercussions of delays or inefficiencies....

As African nations begin to ease lockdown restrictions, health systems are bracing to prevent the novel coronavirus from spreading rapidly...

The spread of COVID-19 has been a wake-up call to the world about dangers posed by over-reliance on single-country sources in the global...

What happens when patients who receive a trusted treatment start experiencing adverse reactions? And what can be done to help prevent it from...

When patients are administered biological treatments created from their own bodies - autologous regenerative medicines - every second counts....

By the year 2020, biopharmaceuticals are estimated to account for 50% of the most successful pharmaceutical products. (1)(2) Biologics, such as...

The challenges posed by COVID-19 transcend international borders and require global solutions. This includes addressing the potential for...

Key takeaways USP’s Emerging Standards Platform enables earlier scientific engagement by sharing analytical methods and approaches while they...

Key takeaways Africa’s regulatory systems for medicines are entering a new phase of their evolution—where years of system strengthening have the...